Private Equity Deals & Transactions TPG in $2.9bn pharma exit The firm is exiting Aptalis, which it acquired in 2008 for $1.3bn. Chelsea Stevenson - 8 January 2014 Share A- A+ 100% Create an account to continue reading Gain instant access to our expert editorial analysis and in-depth insight. Register for free Already have an account? Sign in
